Zobrazeno 1 - 7
of 7
pro vyhledávání: '"Christopher Benko"'
Publikováno v:
Clinical and Translational Science, Vol 13, Iss 5, Pp 838-841 (2020)
The coronavirus disease 2019 (COVID‐19) pandemic has rapidly challenged the pharmaceutical industry to implement remote clinical trials. The industry’s lack of extensive experience with remote measurements initiates multiple questions about how t
Externí odkaz:
https://doaj.org/article/38afb59171054be7b7478b35e2f9b273
Autor:
Elena S. Izmailova, Ian L. McLean, Greg Hather, David Merberg, Jason Homsy, Matthew Cantor, Dmitri Volfson, Gaurav Bhatia, Eric D. Perakslis, Christopher Benko, John A. Wagner
Publikováno v:
Clinical and Translational Science, Vol 12, Iss 6, Pp 677-686 (2019)
Wearable digital devices offer potential advantages over traditional methods for the collection of health‐related information, including continuous collection of dense data while study subjects are ambulatory or in remote settings. We assessed the
Externí odkaz:
https://doaj.org/article/90670d7afa5640249e7ccb5cebc8272f
Autor:
Elena S. Izmailova, Ian L. McLean, Gaurav Bhatia, Greg Hather, Matthew Cantor, David Merberg, Eric D. Perakslis, Christopher Benko, John A. Wagner
Publikováno v:
Clinical and Translational Science, Vol 12, Iss 3, Pp 247-256 (2019)
We assessed the performance of two US Food and Drug Administration (FDA) 510(k)‐cleared wearable digital devices and the operational feasibility of deploying them to augment data collection in a 10‐day residential phase I clinical trial. The Phil
Externí odkaz:
https://doaj.org/article/1f0bf78ce5664445aecc9ea2e7c54b04
Publikováno v:
Clinical and Translational Science, Vol 13, Iss 5, Pp 838-841 (2020)
Clinical and Translational Science
Clinical and Translational Science
The coronavirus disease 2019 (COVID-19) pandemic has rapidly challenged the pharmaceutical industry to implement remote clinical trials. The industry's lack of extensive experience with remote measurements initiates multiple questions about how to se
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::4914234d122e732184e4914009c8aa56
https://doaj.org/article/38afb59171054be7b7478b35e2f9b273
https://doaj.org/article/38afb59171054be7b7478b35e2f9b273
Autor:
Matthew Cantor, Gaurav Bhatia, Qinlei Huang, Christina Walters, S. Aubrey Stoch, Liesbeth Cluckers, Tami Crumley, Sylvie Rottey, Elena S. Izmailova, Radha Railkar, Christopher Benko, Ingeborg Heirman
Publikováno v:
Clinical Pharmacology & Therapeutics. 107:948-956
Mobile health (mHealth) technologies have the potential to capture dense patient data on the background of real-life behavior. Merck & Co., Inc. (Kenilworth, NJ), in collaboration with Koneksa Health, conducted a phase I clinical trial to validate ca
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::3b3e0f7a24c14d603c9183b23fc8cfd9
https://doi.org/10.1002/cpt.1790
https://doi.org/10.1002/cpt.1790
Autor:
Jason Homsy, Gaurav Bhatia, David Merberg, Matthew Cantor, John A. Wagner, Eric D. Perakslis, Dmitri Volfson, Greg Hather, Christopher Benko, Elena S. Izmailova, Ian L. McLean
Publikováno v:
Clinical and Translational Science
Clinical and Translational Science, Vol 12, Iss 6, Pp 677-686 (2019)
Clinical and Translational Science, Vol 12, Iss 6, Pp 677-686 (2019)
Wearable digital devices offer potential advantages over traditional methods for the collection of health-related information, including continuous collection of dense data while study subjects are ambulatory or in remote settings. We assessed the ut
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::fa1e07c59ffa0740c4bb844d28992816
http://europepmc.org/articles/PMC6853263
http://europepmc.org/articles/PMC6853263
Autor:
Greg Hather, Eric D. Perakslis, Christopher Benko, David Merberg, Gaurav Bhatia, Matthew Cantor, John A. Wagner, Ian L. McLean, Elena S. Izmailova
Publikováno v:
Clinical and Translational Science
Clinical and Translational Science, Vol 12, Iss 3, Pp 247-256 (2019)
Clinical and Translational Science, Vol 12, Iss 3, Pp 247-256 (2019)
We assessed the performance of two US Food and Drug Administration (FDA) 510(k)‐cleared wearable digital devices and the operational feasibility of deploying them to augment data collection in a 10‐day residential phase I clinical trial. The Phil
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::300ccf421dba066db9d07959b1e36d71
https://doi.org/10.1111/cts.12602
https://doi.org/10.1111/cts.12602